Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 44

1.

I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?

Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, Cohen JM, Oroszi B, Rizzo C, Machado A, Pitigoi D, Domegan L, Paradowska-Stankiewicz I, Buchholz U, Gherasim A, Daviaud I, Horváth JK, Bella A, Lupulescu E, O Donnell J, Korczyńska M, Moren A; I-MOVE case–control study team.

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30201.

PMID:
27124420
2.

Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.

Gherasim A, Pozo F, de Mateo S, Aspiritxaga Gamarra I, García-Cenoz M, Vega T, Martínez E, Giménez J, Castrillejo D, Larrauri A; cycEVA team and the VEVA Working Group.

Vaccine. 2016 Apr 29;34(20):2371-7. doi: 10.1016/j.vaccine.2016.03.035. Epub 2016 Mar 25.

PMID:
27020713
3.

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.

Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz IA, Bella A, Larrauri A, Ferenczi A; Joan O´Donell, Lazar M, Pechirra P, Korczyńska MR, Pozo F, Moren A; I-MOVE multicentre case–control team.

Euro Surveill. 2016;21(7). doi: 10.2807/1560-7917.ES.2016.21.7.30139.

PMID:
26924024
4.

Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.

Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Rodriguez C, Vega T, Quinones C, Martinez E, Vanrell JM, Gimenez J, Castrillejo D, Altzibar JM, Carril F, Ramos JM, Serrano MC, Martinez A, Torner N, Perez E, Gallardo V, Larrauri A; Spanish Influenza Sentinel Surveillance System.

Euro Surveill. 2015 Jul 16;20(28). pii: 21187. Erratum in: Euro Surveill. 2015;20(29):21190.

5.

Influenza surveillance in Europe: comparing intensity levels calculated using the moving epidemic method.

Vega T, Lozano JE, Meerhoff T, Snacken R, Beauté J, Jorgensen P, Ortiz de Lejarazu R, Domegan L, Mossong J, Nielsen J, Born R, Larrauri A, Brown C.

Influenza Other Respir Viruses. 2015 Sep;9(5):234-46. doi: 10.1111/irv.12330.

6.

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014.

Jiménez-Jorge S, Pozo F, Larrauri A; cycEVA Study Team.

Vaccine. 2015 Jun 26;33(29):3276-80. doi: 10.1016/j.vaccine.2015.03.051. Epub 2015 Apr 11.

PMID:
25869892
7.

Excess mortality among the elderly in European countries, December 2014 to February 2015.

Molbak K, Espenhain L, Nielsen J, Tersago K, Bossuyt N, Denissov G, Baburin A, Virtanen M, Fouillet A, Sideroglou T, Gkolfinopoulou K, Paldy A, Bobvos J, van Asten L, de Lange M, Nunes B, da Silva S, Larrauri A, Gomez IL, Tsoumanis A, Junker C, Green H, Pebody R, McMenamin J, Reynolds A, Mazick A.

Euro Surveill. 2015 Mar 19;20(11). pii: 21065.

8.

[Excess mortality associated with influenza in Spain in winter 2012].

León-Gómez I, Delgado-Sanz C, Jiménez-Jorge S, Flores V, Simón F, Gómez-Barroso D, Larrauri A, de Mateo Ontañón S.

Gac Sanit. 2015 Jul-Aug;29(4):258-65. doi: 10.1016/j.gaceta.2015.01.011. Epub 2015 Mar 12. Spanish.

9.

[Monitoring respiratory syncytial virus through the Spanish influenza surveillance system, 2006-2014].

Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; en representación del Sistema de Vigilancia de la Gripe en España (SVGE).

Enferm Infecc Microbiol Clin. 2016 Feb;34(2):117-20. doi: 10.1016/j.eimc.2014.12.012. Epub 2015 Feb 19. Spanish.

PMID:
25703209
10.

Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.

Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; Spanish Influenza Surveillance System.

Vaccine. 2014 Jul 31;32(35):4404-11. doi: 10.1016/j.vaccine.2014.06.063. Epub 2014 Jun 23.

PMID:
24968153
11.

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.

Jimenez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, Garcia-Cenoz M, Castilla J, Sancho R, Etxebarriarteun-Aranzabal L, Quinones C, Martinez E, Vega T, Garcia A, Gimenez J, Vanrell JM, Castrillejo D, Larrauri A; Spanish Influenza Sentinel Surveillance System (SISS).

Euro Surveill. 2014 Mar 6;19(9). pii: 20727.

12.

Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.

Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, Rogalska J, Pitigoi D, Paradowska-Stankiewicz I, Reuss A, Jiménez-Jorge S, Daviaud I, Guiomar R, O'Donnell J, Necula G, Głuchowska M, Moren A.

Euro Surveill. 2014 Feb 13;19(6). pii: 20701.

13.

Geographical spread of influenza incidence in Spain during the 2009 A(H1N1) pandemic wave and the two succeeding influenza seasons.

Gomez-Barroso D, Martinez-Beneito MA, Flores V, Amorós R, Delgado C, Botella P, Zurriaga O, Larrauri A; Scientific Committee of Project GR09/020.

Epidemiol Infect. 2014 Dec;142(12):2629-41. doi: 10.1017/S0950268813003439. Epub 2014 Jan 27.

PMID:
24476599
14.

Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.

Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Pérez E, Gallardo V, Rodriguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Serrano Mdel C, Ramos JM, Larrauri A; Spanish Influenza Sentinel Surveillance System.

BMC Infect Dis. 2013 Sep 22;13:441. doi: 10.1186/1471-2334-13-441.

15.

Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.

Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jiménez-Jorge S, Horváth JK, Daviaud I, Guiomar R, Necula G, Bella A, O'Donnell J, Głuchowska M, Ciancio BC, Nicoll A, Moren A.

Euro Surveill. 2013 Jan 31;18(5). pii: 20390.

16.

Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.

Jimenez-Jorge S, de Mateo S, Pozo F, Casas I, Garcia Cenoz M, Castilla J, Gallardo V, Perez E, Vega T, Rodriguez C, Quinones C, Martinez E, Gimenez J, Vanrell J, Castrillejo D, Serrano M, Ramos J, Larrauri A.

Euro Surveill. 2012 Mar 22;17(12). pii: 20129.

17.

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.

Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A; cycEVA Study Team; Spanish Influenza Sentinel Surveillance System.

Vaccine. 2012 May 21;30(24):3595-602. doi: 10.1016/j.vaccine.2012.03.048. Epub 2012 Mar 31.

PMID:
22472792
18.

Influenza-related mortality in Spain, 1999-2005.

López-Cuadrado T, de Mateo S, Jiménez-Jorge S, Savulescu C, Larrauri A.

Gac Sanit. 2012 Jul-Aug;26(4):325-9. doi: 10.1016/j.gaceta.2011.09.033. Epub 2012 Jan 28.

19.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A.

BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899.

20.

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, Stefanoff P, Nunes B, Pitigoi D, Larrauri A, Daviaud I, Horvath JK, O'Donnell J, Seyler T, Paradowska-Stankiewicz IA, Pechirra P, Ivanciuc AE, Jiménez-Jorge S, Savulescu C, Ciancio BC, Moren A.

PLoS One. 2011;6(11):e27622. doi: 10.1371/journal.pone.0027622. Epub 2011 Nov 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk